OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 19

Showing 19 citing articles:

mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Sulaiman K. Marafie, Fahd Al‐Mulla, Jehad Abubaker
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6141-6141
Open Access | Times Cited: 15

Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1

Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
Yue Liu, Isabelle Lomeli, Stephen J. Kron
Cells (2024) Vol. 13, Iss. 15, pp. 1281-1281
Open Access | Times Cited: 7

Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access

Regulatory Roles of Exosomes in Aging and Aging-Related Diseases
Nanyin Xiao, Li Qiao, Guangyu Liang, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Closed Access

Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation
Chenxing Zhang, Jiaxin Liu, Tiejun Gu, et al.
Breast Cancer Research and Treatment (2025)
Closed Access

Integrating cuproptosis and immunosenescence: A novel therapeutic strategy in cancer treatment
Ali Ahmadizad Firouzjaei, Seyed Hamid Aghaee‐Bakhtiari
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101983-101983
Closed Access

Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity—A Narrative Review
Yicong Liang, Devesh Kaushal, Robert Wilson
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7943-7943
Open Access | Times Cited: 2

PD-1 immunology in the kidneys: a growing relationship
Ruyue Chen, Qiang Lin, Hanyun Tang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights stumor-promoting macrophage cells in Glioblastoma
Han Cheng, Yan Yan, Biao Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Impact of senescence cell signature in patients with non-small cell carcinoma and melanoma receiving PD-L1/PD-1 inhibitors
Young Wha Koh, Jae-Ho Han, Seokjin Haam, et al.
Mechanisms of Ageing and Development (2024) Vol. 222, pp. 111999-111999
Closed Access | Times Cited: 1

Can tissue-specific PD-1/PD-L1 targeting combined with other immune checkpoint blockades enhance immune clearance?
Sadia Ahmad, Amna Rehman, Ali Afzal, et al.
Medical Hypotheses (2024), pp. 111491-111491
Closed Access

PML Nuclear Bodies and Cellular Senescence: A Comparative Study of Healthy and Premature Aging Syndrome Donors’ Cells
Eugene Y. Smirnov, Sergey A. Silonov, Eva A. Shmidt, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2075-2075
Open Access

Page 1

Scroll to top